Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Fulminant Myocarditis: A Review of Contemporary Literature

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2022 Feb 25

PMID 35208538

Authors

Shreyas Venkataraman

Abhishek Bhardwaj

Peter Matthew Belford

Benjamin N Morris

David X Zhao

Saraschandra Vallabhajosyula

Affiliations

Soon will be listed here.

Abstract

Fulminant myocarditis is characterized by life threatening heart failure presenting as cardiogenic shock requiring inotropic or mechanical circulatory support to maintain tissue perfusion. There are limited data on the role of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the management of fulminant myocarditis. This review seeks to evaluate the management of fulminant myocarditis with a special emphasis on the role and outcomes with VA-ECMO use.

Citing Articles

Feasibility and Role of Cardiac Magnetic Resonance in Intensive and Acute Cardiovascular Care.

Leo I, Figliozzi S, Ielapi J, Sicilia F, Torella D, Dellegrottaglie S J Clin Med. 2025; 14(4).

PMID: 40004642 PMC: 11856486. DOI: 10.3390/jcm14041112.

Clinical Application of Extracorporeal Membrane Oxygenation in the Treatment of Fulminant Myocarditis.

Fan Z, Wen J, Li B, Liao X Rev Cardiovasc Med. 2024; 25(4):114.

PMID: 39076539 PMC: 11264031. DOI: 10.31083/j.rcm2504114.

Fulminant Myocarditis and Venoarterial Extracorporeal Membrane Oxygenation: A Systematic Review.

Briglio S, Khanduja V, Lothan J, Gorantla V Cureus. 2024; 16(2):e54711.

PMID: 38524063 PMC: 10960644. DOI: 10.7759/cureus.54711.

Need for a Cardiogenic Shock Team Collaborative-Promoting a Team-Based Model of Care to Improve Outcomes and Identify Best Practices.

Senman B, Jentzer J, Barnett C, Bartos J, Berg D, Chih S J Am Heart Assoc. 2024; 13(6):e031979.

PMID: 38456417 PMC: 11009990. DOI: 10.1161/JAHA.123.031979.

Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO).

Swedzky F, Barbagelata A, Perrone S, Kaplinsky E, Ducharme A Drugs Context. 2023; 12.

PMID: 36660011 PMC: 9828876. DOI: 10.7573/dic.2022-7-7.

References

Cooper Jr L . Myocarditis. N Engl J Med. 2009; 360(15):1526-38. PMC: 5814110. DOI: 10.1056/NEJMra0800028. View

Lee H, Kim H, Ahn C, Lee S, Hong S, Yang J . Association Between Timing of Extracorporeal Membrane Oxygenation and Clinical Outcomes in Refractory Cardiogenic Shock. JACC Cardiovasc Interv. 2021; 14(10):1109-1119. DOI: 10.1016/j.jcin.2021.03.048. View

Vallabhajosyula S, Prasad A, Bell M, Sandhu G, Eleid M, Dunlay S . Extracorporeal Membrane Oxygenation Use in Acute Myocardial Infarction in the United States, 2000 to 2014. Circ Heart Fail. 2019; 12(12):e005929. PMC: 7015104. DOI: 10.1161/CIRCHEARTFAILURE.119.005929. View

Law Y, Lal A, Chen S, cihakova D, Cooper Jr L, Deshpande S . Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association. Circulation. 2021; 144(6):e123-e135. DOI: 10.1161/CIR.0000000000001001. View

Daniels C, Rajpal S, Greenshields J, Rosenthal G, Chung E, Terrin M . Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021; 6(9):1078-1087. PMC: 8160916. DOI: 10.1001/jamacardio.2021.2065. View

Vallabhajosyula S, Patlolla S, Sandhyavenu H, Vallabhajosyula S, Barsness G, Dunlay S . Periprocedural Cardiopulmonary Bypass or Venoarterial Extracorporeal Membrane Oxygenation During Transcatheter Aortic Valve Replacement: A Systematic Review. J Am Heart Assoc. 2018; 7(14). PMC: 6064861. DOI: 10.1161/JAHA.118.009608. View

Italia L, Tomasoni D, Bisegna S, Pancaldi E, Stretti L, Adamo M . COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front Cardiovasc Med. 2021; 8:713560. PMC: 8382715. DOI: 10.3389/fcvm.2021.713560. View

Sharma A, Stultz J, Bellamkonda N, Amsterdam E . Fulminant Myocarditis: Epidemiology, Pathogenesis, Diagnosis, and Management. Am J Cardiol. 2019; 124(12):1954-1960. DOI: 10.1016/j.amjcard.2019.09.017. View

Vallabhajosyula S, OHoro J, Antharam P, Ananthaneni S, Vallabhajosyula S, Stulak J . Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock. ASAIO J. 2019; 66(5):497-503. DOI: 10.1097/MAT.0000000000001039. View

10.

Rajaram S, Desai N, Kalra A, Gajera M, Cavanaugh S, Brampton W . Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev. 2013; (2):CD003408. PMC: 6517063. DOI: 10.1002/14651858.CD003408.pub3. View

11.

Chen J, Spanier T, Gonzalez J, Marelli D, Flannery M, Tector K . Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant. 1999; 18(4):351-7. DOI: 10.1016/s1053-2498(98)00054-0. View

12.

Marelli D, Laks H, Amsel B, Jett G, Couper G, Ardehali A . Temporary mechanical support with the BVS 5000 assist device during treatment of acute myocarditis. J Card Surg. 1997; 12(1):55-9. DOI: 10.1111/j.1540-8191.1997.tb00091.x. View

13.

Binanay C, Califf R, Hasselblad V, OConnor C, Shah M, Sopko G . Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005; 294(13):1625-33. DOI: 10.1001/jama.294.13.1625. View

14.

Caforio A, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A . Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010; 96(10):779-84. DOI: 10.1136/hrt.2009.187138. View

15.

den Uil C, Akin S, Jewbali L, Dos Reis Miranda D, Brugts J, Constantinescu A . Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017; 52(1):14-25. DOI: 10.1093/ejcts/ezx088. View

16.

Lorusso R, Centofanti P, Gelsomino S, Barili F, Di Mauro M, Orlando P . Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience. Ann Thorac Surg. 2015; 101(3):919-26. DOI: 10.1016/j.athoracsur.2015.08.014. View

17.

Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G . A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013; 15(3):172-8. View

18.

Cooper Jr L, Hare J, Tazelaar H, Edwards W, Starling R, Deng M . Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol. 2008; 102(11):1535-9. PMC: 2613862. DOI: 10.1016/j.amjcard.2008.07.041. View

19.

Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D . Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005; 45(11):1815-22. DOI: 10.1016/j.jacc.2004.11.069. View

20.

Vallabhajosyula S, Arora S, Sakhuja A, Lahewala S, Kumar V, Shantha G . Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock. Am J Cardiol. 2018; 123(3):489-497. DOI: 10.1016/j.amjcard.2018.10.029. View